1893P Immune-related adverse events from contemporary first-line combination therapies in metastatic renal cell carcinoma: Results from the IMDC

Autor: Navani, V., Lemelin, A., Powles, T.B., Liow, E.C.H., Wong, S.S.L., Meza, L.A., Ebrahimi, H., Saliby, R.M., Saad, E., Yuasa, T., Wood, L.A., Kollmannsberger, C.K., Graham, J., North, S., Basappa, N.S., Donskov, F., Rodriguez, C. Suarez, Lalani, A-K., Choueiri, T.K., Heng, D.Y.C.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S1018-S1019
Databáze: ScienceDirect